期刊文献+

蛋白酪氨酸激酶抑制剂对视网膜趋化因子表达的影响 被引量:1

原文传递
导出
摘要 视网膜是眼后节趋化因子的主要来源,趋化因子在多种致盲性眼底疾病的发生、发展过程中起着重要作用。白介素-8(IL-8)与葡萄膜炎、增生性糖尿病视网膜病变(PDR)关系密切。增生性玻璃体视网膜病变(PVR)和PDR患者玻璃体中单核细胞趋化蛋白-1(MCP-1)水平明显升高。最近的研究表明MCP-1可能参与了老年性黄斑变性中脉络膜新生血管形成的早期过程。因此通过抑制趋化因子在视网膜的表达可能成为眼底疾病新的治疗手段。
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2007年第2期140-141,共2页 Chinese Journal of Ocular Fundus Diseases
  • 相关文献

参考文献9

  • 1Crane IJ, Wallace CA, McKillop-Smith S, et al. Control of chemokine production at the blood-retina barrier. Immunology,2000,101 : 426-433.
  • 2Mantas C, Direskeneli H, Oz D, et al. IL-8 producing cells in patients with Behcets's disease. Clin Exp Rheumatol, 2000, 18:249-251.
  • 3Doganay S, Evereklioglu C, Er H, et al. Comparison of serum NO, TNF-alpha, IL-1 beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye,2002,16: 163-170.
  • 4Capeans C, De Rojas MV, Lojo S, et al. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy. Retina, 1998, 18: 546-550.
  • 5Grossniklaus HE, Ling JX, Wallace TM, et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis, 2002, 8: 119-126.
  • 6Jo N, Wu GS, Rao NA. Upregulation of chemokine expression in the retinal vasculature in ischemia-reperfusion injury. Invest Ophthalmol Vis Sci, 2003, 44:4054-4060.
  • 7Naim M, Gestetner B, Kirson I, et al. A new isoflavone from soya beans. Phytochem, 1973,12:169-170.
  • 8Majji AB, Hayashi A, Kim HC, et al. Inhibition of choriocapilliaris regeneration with genistein. Invest Ophthalmol Vis Sci, 1999,40:1477-1486.
  • 9Koroma BM, de Juan E Jr. Phosphotyrosine inhibitor and control of vascular endothelial cell proliferation by genistein. Biochem Pharmacol, 1994,48:1126-1129.

同被引文献20

  • 1李岱,曾水清,陈晓,胡世兴.粉防己碱抑制激光诱导鼠脉络膜新生血管[J].中华眼底病杂志,2006,22(4):242-244. 被引量:7
  • 2徐建锋,王雨生,杨秀梅,张鹏,侯慧媛,石圆圆,马吉献,宋存先,张涛.地塞米松-聚乳酸-羟基乙酸纳米粒玻璃体内注射对激光诱导的大鼠脉络膜新生血管的抑制作用[J].中华眼底病杂志,2007,23(1):33-37. 被引量:4
  • 3Cao J, Zhao L, Li Y, et al. A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated inflammation and fibrosis by VEGF trap. lnvest Ophthalmol Vis Sci,2010,51 : 6009-6017.
  • 4Bhutto IA, McLeod DS, Merges C, et al. I.ocalisation of SDF-1 and its receptor CXCR4 in retina and choroid of aged human eyes and in eyes with age related macular degeneration. Br J Ophthalmol, 2006,90 : 906 910.
  • 5Neuhaus T, Stier S, Totzke G, et al. Stromal cell-derived factor 1alpha (SDF-lalpha) induces gene-expression of early growth response 1 (Egr-1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation. Cell Prolif,2003, 36 : 75-86.
  • 6Salvucci O, Lei Y, Villalba S, et al. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal derivied factor-1. Blood,2002,99:2703-2711.
  • 7Xu L, Duda DG, di Tomaso E, et al. Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDFlalpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer. Cancer Res, 2009,69 : 7905-7910.
  • 8Yu L, Wu X, Cheng Z, et al. Interaction between bevacizumab and murine VEGF-A: a reassessment. Invest Ophthalmol Vis Sei,2008,49: 522 -527.
  • 9Klein R, Peto T, Bird A, et al. The epidemiology of age-related macular degeneration. Am J Ophthalmol, 2004,137 : 486-495.
  • 10Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med,2006,355: 1432-1444.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部